Unlike other GHSs, ipamorelin does not significantly affect ACTH or cortisol levels, even at high doses, ensuring targeted GH release (1)
In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support
doi: 10.3389/fnmol.2024.1408159 Received 27 March 2024 Accepted 14 June 2024 Published 09 July 2024 Volume 17 - 2024 Edited by Eva Zerovnik, Institut Joef Stefan (IJS), Slovenia Reviewed by Jeffrey Liddell, The University of Melbourne, Australia Ali Yousefian-Jazi, Korea Institute of Science and Technology (KIST), Republic of Korea Updates Copyright 2024 Min, Sarlus and Harris
Insert the needle into the area you hold at a 90-degree angle
& Adams, P